Cover: Vascular Access Procedures for End-Stage Renal Disease Medicare Beneficiaries

Vascular Access Procedures for End-Stage Renal Disease Medicare Beneficiaries

Published 1993

by Joel Kallich, Martin Markovich, Mark Litwin

Download eBook for Free

FormatFile SizeNotes
PDF file 1.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

This report describes the findings of a project of the RAND/UCLA/Harvard Center for Policy Research in Health Care Financing, which is supported by the Health Care Financing Administration. This report examines several factors believed to affect the rate of shunt creations and complications for Medicare beneficiaries who suffer from end stage renal disease (ESRD). Because Medicare's ESRD program provides health care coverage to individuals with a chronic disease, regardless of age, this work should be of interest to all those concerned with health care service delivery to a chronically ill population.

This report is part of the RAND draft series. The unrestricted draft was a product of RAND from 1993 to 2003 that represented preliminary or prepublication versions of other more formal RAND products for distribution to appropriate external audiences. The draft could be considered similar to an academic discussion paper. Although unrestricted drafts had been approved for circulation, they were not usually formally edited or peer reviewed.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.